The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae

被引:46
作者
Wong, YK
Sueur, JM
Fall, CHD
Orfila, J
Ward, ME
机构
[1] Southampton Gen Hosp, Wessex Cardiothorac Unit, Southampton SO16 6YD, Hants, England
[2] Biobanque Picardie, Amiens, France
[3] Univ Southampton, MRC, Environm Epidemiol Unit, Southampton SO9 5NH, Hants, England
[4] Univ Southampton, Dept Mol Microbiol, Southampton SO9 5NH, Hants, England
关键词
microimmunofluorescence rest; time resolved fluoroscopic immunoassay; chlamydia;
D O I
10.1136/jcp.52.2.99
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To examine the species specificity of the microimmunofluorescence test (MIF) and assess a time resolved fluoroscopic immunoassay (TRIA) for measuring IgG antibodies to C pneumoniae. Methods-Sera from 1020 subjects were tested by MIF for IgG, IgM, and IgA antibodies to C pneumoniae, C trachomatis, and C psittaci; 501 serum samples were also tested by TRIA for IgG antibodies to C pneumoniae. Results-C pneumoniae antibody titres as measured by MIF were correlated with those for C psittaci and C trachomatis. It was estimated that on average, one third of the twofold dilution steps that make up the final C pneumoniae antibody titre may be due to cross reacting genus specific antibody. The results of TRIA correlated well with those of MIF. In 75% of cases, the TRIA result predicted a three titre range within which the actual MIF result would fall. Conclusions-MIF does not appear to be as species specific as claimed. TRIA is unlikely to be as specific but as it is completely objective, easier to perform, amenable to automation, and gives reproducible results, it is a rapid and useful method for comparing populations.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 13 条
[1]   Characterization of serum antibody response to chlamydiae in patients with sexually acquired reactive arthritis [J].
Domeika, K ;
Brade, L ;
Mardh, PA ;
Brade, H ;
Witkin, SS ;
Domeika, M .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1997, 19 (03) :191-202
[2]   SEROTYPING OF CHLAMYDIA-PSITTACI BY THE MICRO-IMMUNOFLUORESCENCE TEST - ISOLATES OF OVINE ORIGIN [J].
EB, F ;
ORFILA, J .
INFECTION AND IMMUNITY, 1982, 37 (03) :1289-1291
[3]   EVALUATION OF SEROLOGICAL METHODS IN THE DIAGNOSIS OF CHLAMYDIA-PNEUMONIAE PNEUMONIA DURING AN EPIDEMIC IN FINLAND [J].
EKMAN, MR ;
LEINONEN, M ;
SYRJALA, H ;
LINNANMAKI, E ;
KUJALA, P ;
SAIKKU, P .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (10) :756-760
[4]   Growth in infancy, infant feeding, childhood living conditions, and Helicobacter pylori infection at age 70 [J].
Fall, CHD ;
Goggin, PM ;
Hawtin, P ;
Fine, D ;
Duggleby, S .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (04) :310-314
[5]   A NEW CHLAMYDIA-PSITTACI STRAIN, TWAR, ISOLATED IN ACUTE RESPIRATORY-TRACT INFECTIONS [J].
GRAYSTON, JT ;
KUO, CC ;
WANG, SP ;
ALTMAN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (03) :161-168
[6]   A SEROEPIDEMIOLOGIC STUDY OF CHLAMYDIA-PNEUMONIAE IN RHODE-ISLAND - EVIDENCE OF SEROLOGIC CROSS-REACTIVITY [J].
KERN, DG ;
NEILL, MA ;
SCHACHTER, J .
CHEST, 1993, 104 (01) :208-213
[7]   ENZYME-IMMUNOASSAY TO DETERMINE EXPOSURE TO CHLAMYDIA-PNEUMONIAE (STRAIN TWAR) [J].
LADANY, S ;
BLACK, CM ;
FARSHY, CE ;
OSSEWAARDE, JM ;
BARNES, RC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (12) :2778-2783
[8]   SPECIFICITY OF THE MICROIMMUNOFLUORESCENCE ASSAY FOR THE SERODIAGNOSIS OF CHLAMYDIA-PNEUMONIAE INFECTIONS [J].
OZANNE, G ;
LEFEBVRE, J .
CANADIAN JOURNAL OF MICROBIOLOGY, 1992, 38 (11) :1185-1189
[9]  
Peeling RW, 1998, CHLAMYDIAL INFECT, P159
[10]   SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART-DISEASE AND ACUTE MYOCARDIAL-INFARCTION [J].
SAIKKU, P ;
MATTILA, K ;
NIEMINEN, MS ;
HUTTUNEN, JK ;
LEINONEN, M ;
EKMAN, MR ;
MAKELA, PH ;
VALTONEN, V .
LANCET, 1988, 2 (8618) :983-986